ClinicalTrials.gg
RecruitingNCT05990218Updated Dec 13, 2024

Artificial Intelligence in the Detection of Right Sided Colonic Polyp in Different Operator Experience

An interventional study of Artificial intellegence. CADe syste, and control in Colon Polyp, sponsored by Department of Medical Services Ministry of Public Health of Thailand. Recruiting at 1 site in Thailand. Open to participants aged 40 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-13.

Sponsored by Department of Medical Services Ministry of Public Health of Thailand · Not applicable, Interventional, and Screening

From the registry’s dates

  • Primary completion was expected by Feb 2026, 8 months ago, but the record still lists the study as recruiting.
  • Registered 5 months after the study started (first participant enrolled Feb 2023, registered Aug 2023).
  • Started Feb 2023; still recruiting 3 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Study summary

Colonoscopy is the gold standard modality for the detection of colonic polyp. However, miss polyp occurs especially in right sided colon. Artificial intelligence (AI) is one of the modality to improve polyp detection but the benefit of AI in operators with different endoscopic experience is still limited. This study aimed to evaluate the efficacy of AI in the detection of right sided colonic polyp in operators with different endoscopic experience by using double insertion of right side colon, back-to-back basis.

02

Conditions studied

  • Colon Polyp

Browse trials for

Keywords

  • colon polyp
  • artificial intellegence
  • colonoscopy
03

In context

Colonic Polyps

377 studies on the registry are indexed under Colonic Polyps; 57 are open to participants now.

This study's planned enrollment of 240 is below the median of 274 across 250 interventional studies indexed under Colonic Polyps.

Browse Colonic Polyps studies →

Lead sponsor

Department of Medical Services Ministry of Public Health of Thailand is the lead sponsor of 39 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • participants age 40-80 years

Exclusion criteria

Exclusion Criteria:

  • History of colonic surgery (except appendectomy)
  • Lower gastrointestinal bleeding
  • unstable vital sign during endoscopy of pregnancy
  • history of inflammatory bowel disease, polyposis syndrome, colon cancer, colonic stricture, abnormal coaglulation, organ failure
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
240 participants (estimated)

Study arms

  • Active comparator
    control, experienced

    Patients received colonoscopy with double insertion of right sided colon under white light by experienced endoscopist

    Device: control

  • Active comparator
    control, beginner

    Patients received colonoscopy with double insertion of right sided colon under white light by beginner endoscopist

    Device: control

  • Experimental
    AI, experience

    Patients received colonoscopy with double insertion of right sided colon under AI by experienced endoscopist

    Device: Artificial intellegence. CADe syste,

  • Experimental
    AI, beginner

    Patients received colonoscopy with double insertion of right sided colon under AI by beginner endoscopist

    Device: Artificial intellegence. CADe syste,

Interventions

  • DeviceArtificial intellegence. CADe syste,

    The patient received endoscopy under CADe system for polyp detection during second endoscopic withdrawal.

  • Devicecontrol

    The patient received endoscopy under conventional white light for polyp detection during second endoscopic withdrawal.

06

What researchers measure

Primary outcomes

  1. polyp detection rate

    the number of polyp detected during endoscopy

    Time frame: during endoscopy

Secondary outcomes

  1. type of polyp

    the type of polyp detected during endoscopy

    Time frame: during endoscopy

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Kamba S, Tamai N, Saitoh I, Matsui H, Horiuchi H, Kobayashi M, Sakamoto T, Ego M, Fukuda A, Tonouchi A, Shimahara Y, Nishikawa M, Nishino H, Saito Y, Sumiyama K. Reducing adenoma miss rate of colonoscopy assisted by artificial intelligence: a multicenter randomized controlled trial. J Gastroenterol. 2021 Aug;56(8):746-757. doi: 10.1007/s00535-021-01808-w. Epub 2021 Jul 3. PubMed 34218329 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2023 (actual). Primary completion is estimated for Feb 2026, 35 months after the start.

Of 132 non-industry interventional studies with no phase under Colonic Polyps, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 35. This study's planned 35 months is above that.

Counting every sponsor, half of 149 studies reached it within 17 months; a quarter within 9 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 6, 2023
First posted
Aug 14, 2023
StartActual
Feb 13, 2023
Primary completionEst.
Feb 12, 2026
CompletionEst.
Feb 28, 2026
Last update
Dec 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05990218
Lead sponsor
Department of Medical Services Ministry of Public Health of Thailand
Responsible party
Sponsor
First posted
Aug 14, 2023
Start date
Feb 13, 2023
Primary completion
Feb 12, 2026 (estimated)
Completion
Feb 28, 2026 (estimated)
Last update
Dec 13, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion